Home » Topics » BioWorld Science

BioWorld Science
RSS

Changing splicing lowers mutant Huntingtin

Dec. 29, 2021

Blocking PAI-1 inhibits experimental PTSD development

Dec. 29, 2021

Emendo Biotherapeutics develops CRISPR-based ex-vivo gene editing strategy for ELANE neutropenia

Dec. 29, 2021

Roche identifies new antibacterials

Dec. 29, 2021

TOPADUR Pharma identifies dual PDE5A inhibitors/soluble guanylate cyclase activators

Dec. 29, 2021

New USP30 inhibitors identified at Mission Therapeutics

Dec. 29, 2021

New RIPK1 inhibitors discovered at Sanofi

Dec. 29, 2021

Boehringer Ingelheim, Vanderbilt University describe mutant GTPase KRAS inhibitors

Dec. 29, 2021

Red seaweed-derived iota-carrageenan shows in vitro activity against SARS-CoV-2 and VOCs

Dec. 29, 2021

New triglyceride-mimetic structure-gated prodrug nanoplatform for precise tumor drug delivery

Dec. 29, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...